ClinicalTrials.gov
public full text
Public Domain
A Study of LY2603618 in Combination With Gemcitabine in Participants With Solid Tumors
The primary objective of this study is to evaluate the safety and tolerability of LY2603618 in combination with the standard dose of gemcitabine up to the global recommended dose of LY2603618 in Japanese participants with solid advanced or metastatic tumors.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer#994866
- Carboplatin and Gemcitabine in Treating Patients With Advanced Solid Tumors#895477
- GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors#829740
- C14 Study in Oncology Patients With Advanced and/or Metastatic Solid Tumors#1009958
- Study of GemOx and Vandetanib in Advanced Solid Malignancy#1138888
Record · ID 844206
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive